Article
RANKL signaling sustains primary tumor growth in genetically engineered mouse models of lung adenocarcinoma
2017-05-26
Abstract excerpt
<h4>Summary</h4> <h4>Hypothesis</h4> Non-small cell lung cancer (NSCLC) is the leading cause of cancer mortality. Recent retrospective clinical analyses suggest that blocking the receptor activator of NF-κB (RANK) signaling pathway inhibits the growth of NSCLC and might represent a new treatment strategy. <h4>Methods</h4> RANK and RANKL expression in human lung adenocarcinoma was interrogated from publicly ava...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- eec23124-8502-53f2-84a8-c13cfbce78f3
- DOI
- 10.1101/142620
